[Prostate cancer]

Gan To Kagaku Ryoho. 1997 Nov;24(14):2092-7.
[Article in Japanese]

Abstract

Up to stage B1 or prostate cancer with N0-1 positive lymph node may be curable by monotherapy of either radical prostatectomy or irradiation. Localized but more advanced stages (B2 and C), however, are difficult to cure. To further improve the prognosis in these stages, a new treatment modality is proposed; pelvic lymphadenectomy, followed by irradiation with neoadjuvant and adjuvant endocrine therapy. An average 2-year followup is favorable. Further studies is awaited to make conclusion.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Estrogens / administration & dosage*
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Prostatectomy
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / surgery
  • Radiotherapy Dosage
  • Survival Rate

Substances

  • Androgen Antagonists
  • Estrogens
  • Gonadotropin-Releasing Hormone